News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,641 Results
Type
Article (10798)
Company Profile (17)
Press Release (211824)
Multimedia
Podcasts (8)
Webinars (7)
Section
Business (63669)
Career Advice (428)
Deals (12009)
Drug Delivery (47)
Drug Development (41911)
Employer Resources (57)
FDA (5350)
Job Trends (4971)
News (119677)
Policy (9403)
Tag
Academia (878)
Accelerated approval (16)
Adcomms (4)
Allergies (80)
Alliances (15948)
ALS (96)
Alzheimer's disease (789)
Antibody-drug conjugate (ADC) (166)
Approvals (5519)
Artificial intelligence (172)
Autoimmune disease (70)
Automation (10)
Bankruptcy (96)
Best Places to Work (4346)
BIOSECURE Act (7)
Biosimilars (65)
Biotechnology (20)
Bladder cancer (87)
Brain cancer (25)
Breast cancer (319)
Cancer (2471)
Cardiovascular disease (197)
Career advice (358)
Career pathing (9)
CAR-T (147)
CDC (8)
Celiac Disease (1)
Cell therapy (370)
Cervical cancer (18)
Clinical research (37624)
Collaboration (733)
Compensation (156)
Complete response letters (18)
COVID-19 (1282)
CRISPR (33)
C-suite (338)
Cystic fibrosis (81)
Data (3433)
Denatured (6)
Depression (65)
Diabetes (246)
Diagnostics (2097)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (94)
Drug pricing (70)
Drug shortages (5)
Duchenne muscular dystrophy (120)
Earnings (31410)
Editorial (16)
Employer branding (6)
Employer resources (52)
Events (25203)
Executive appointments (396)
FDA (6977)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (16)
Funding (709)
Gene editing (85)
Generative AI (13)
Gene therapy (273)
GLP-1 (416)
Government (1576)
Grass and pollen (3)
Guidances (263)
Healthcare (6247)
HIV (33)
Huntington's disease (20)
IgA nephropathy (51)
Immunology and inflammation (97)
Immuno-oncology (23)
Indications (61)
Infectious disease (1382)
Inflammatory bowel disease (86)
Inflation Reduction Act (8)
Influenza (58)
Intellectual property (106)
Interviews (91)
IPO (7947)
IRA (22)
Job creations (851)
Job search strategy (278)
JPM (16)
Kidney cancer (13)
Labor market (12)
Layoffs (241)
Leadership (13)
Legal (1402)
Liver cancer (45)
Longevity (8)
Lung cancer (352)
Lymphoma (211)
Machine learning (14)
Management (15)
Manufacturing (295)
MASH (75)
Medical device (4035)
Medtech (4053)
Mergers & acquisitions (4566)
Metabolic disorders (595)
Multiple sclerosis (103)
NASH (7)
Neurodegenerative disease (158)
Neuropsychiatric disorders (35)
Neuroscience (1397)
NextGen: Class of 2026 (1956)
Non-profit (1801)
Obesity (267)
Opinion (92)
Ovarian cancer (91)
Pain (95)
Pancreatic cancer (136)
Parkinson's disease (141)
Partnered (14)
Patents (177)
Patient recruitment (300)
Peanut (39)
People (16561)
Pharmaceutical (7)
Pharmacy benefit managers (8)
Phase 1 (13124)
Phase 2 (16836)
Phase 3 (11421)
Pipeline (3084)
Policy (85)
Postmarket research (927)
Preclinical (3611)
Press Release (12)
Prostate cancer (138)
Psychedelics (7)
Radiopharmaceuticals (131)
Rare diseases (409)
Real estate (1345)
Recruiting (18)
Regulatory (8395)
Reports (22)
Research institute (893)
Resumes & cover letters (80)
Rett syndrome (20)
RNA editing (6)
RSV (23)
Schizophrenia (68)
Series A (101)
Series B (85)
Sickle cell disease (47)
Special edition (2)
Spinal muscular atrophy (83)
Sponsored (20)
Startups (1368)
Stomach cancer (6)
Supply chain (40)
Tariffs (29)
The Weekly (2)
Vaccines (378)
Venture capital (35)
Weight loss (142)
Women's health (42)
Worklife (1)
Date
Today (41)
Last 7 days (220)
Last 30 days (874)
Last 365 days (13104)
2026 (1260)
2025 (13218)
2024 (14619)
2023 (16188)
2022 (20186)
2021 (21244)
2020 (19191)
2019 (14964)
2018 (11480)
2017 (11072)
2016 (9479)
2015 (11703)
2014 (8179)
2013 (5802)
2012 (5987)
2011 (6379)
2010 (5491)
Location
Africa (248)
Alabama (38)
Alaska (4)
Arizona (61)
Arkansas (4)
Asia (14114)
Australia (2743)
California (4747)
Canada (1156)
China (503)
Colorado (186)
Connecticut (224)
Delaware (182)
Europe (30187)
Florida (754)
Georgia (137)
Hawaii (1)
Idaho (14)
Illinois (289)
India (24)
Indiana (235)
Iowa (6)
Japan (237)
Kansas (81)
Kentucky (14)
Louisiana (14)
Maine (22)
Maryland (519)
Massachusetts (3467)
Michigan (118)
Minnesota (172)
Mississippi (4)
Missouri (51)
Montana (13)
Nebraska (7)
Nevada (61)
New Hampshire (33)
New Jersey (1446)
New Mexico (11)
New York (1483)
North Carolina (599)
North Dakota (2)
Northern California (2375)
Ohio (73)
Oklahoma (4)
Oregon (12)
Pennsylvania (946)
Puerto Rico (13)
Rhode Island (13)
South America (294)
South Carolina (16)
South Dakota (1)
Southern California (1844)
Tennessee (52)
Texas (750)
United States (16985)
Utah (130)
Virginia (127)
Washington D.C. (31)
Washington State (408)
West Virginia (2)
Wisconsin (33)
Wyoming (2)
222,641 Results for "initial therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
Initial shipment delivered to distributor warehouse supports expansion into B2B pharmacy distribution alongside direct-to-consumer activities
January 6, 2026
·
5 min read
Press Releases
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
February 3, 2026
·
8 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
·
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
·
4 min read
Press Releases
SpyGlass Pharma Announces Pricing of Initial Public Offering
February 6, 2026
·
3 min read
Press Releases
Novo Nordisk initiates 2026 share repurchase programme
February 4, 2026
·
2 min read
Press Releases
Veradermics Announces Pricing of Upsized Initial Public Offering
February 4, 2026
·
4 min read
Press Releases
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
February 5, 2026
·
3 min read
Press Releases
Organogenesis Announces Initiation of Biologics License Application for ReNu®
December 24, 2025
·
4 min read
Press Releases
Medline Announces Pricing of Upsized Initial Public Offering
December 17, 2025
·
4 min read
1 of 22,265
Next
